Laser Ablation for Benign and Malignant Thyroid Nodules – A
Mini-Literature Review

Roberto      Negro

doi:10.2174/0118715303275468231004105258

Abstract

Background: Thyroid nodules are a common disease in endocrine clinical practice. They are often benign, asymptomatic, and do not require any treatment. But, in a non-negligible proportion, they can cause local symptoms of compression or esthetic concerns. In the last two decades, the advent of laser ablation (LA) has become a valid alternative to surgery for these nodules. Moreover, LA has also been successfully used to treat small thyroid cancers and neck recurrence.

Objective: This study aims to review and summarize the published literature regarding LA in the treatment of benign and malignant thyroid nodules.

Methods: A comprehensive literature search on PubMed from 2000 to 2023 was carried out. The search terms included: thyroid, nodules, laser, cancer, lymph node metastasis, and autonomously functioning nodules. The most relevant investigations in the field were selected.

Results: In the last two decades, a very remarkable number of papers consistently demonstrated that LA is able to durably shrink benign nodules on average by about 50%; better results are obtained in spongiform nodules with a volume less than 15 ml; 500 J/ml of tissue should be administered. LA may be a valid option to treat autonomously functioning nodules and papillary thyroid cancers especially if they are <10 mm, and with neck recurrence in patients already submitted to surgery. LA has also been demonstrated to be cost-effective compared to surgical treatment both in benign and malignant lesions, with similar outcomes.

Conclusion: Evidence demonstrated that LA is a valid alternative to surgery in benign and malignant thyroid lesions, but also to obtain a successful treatment, a careful selection of the lesion is mandatory.

« Previous Next »

Graphical Abstract

[1]
Knudsen, N.; Perrild, H.; Christiansen, E.; Rasmussen, S.; Dige-Petersen, H.; Jørgensen, T. Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur. J. Endocrinol.,  2000, 142(3), 224-230.
 [http://dx.doi.org/10.1530/eje.0.1420224] [PMID: 10700715]

[2]
Reiners, C.; Wegscheider, K.; Schicha, H.; Theissen, P.; Vaupel, R.; Wrbitzky, R.; Schumm-Draeger, P.M. Prevalence of thyroid disorders in the working population of Germany: Ultrasonography screening in 96,278 unselected employees. Thyroid,  2004, 14(11), 926-932.
 [http://dx.doi.org/10.1089/thy.2004.14.926] [PMID: 15671771]

[3]
Kwong, N.; Medici, M.; Angell, T.E.; Liu, X.; Marqusee, E.; Cibas, E.S.; Krane, J.F.; Barletta, J.A.; Kim, M.I.; Larsen, P.R.; Alexander, E.K. The influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk. J. Clin. Endocrinol. Metab.,  2015, 100(12), 4434-4440.
 [http://dx.doi.org/10.1210/jc.2015-3100] [PMID: 26465395]

[4]
Durante, C.; Costante, G.; Lucisano, G.; Bruno, R.; Meringolo, D.; Paciaroni, A.; Puxeddu, E.; Torlontano, M.; Tumino, S.; Attard, M.; Lamartina, L.; Nicolucci, A.; Filetti, S. The natural history of benign thyroid nodules. JAMA,  2015, 313(9), 926-935.
 [http://dx.doi.org/10.1001/jama.2015.0956] [PMID: 25734734]

[5]
Negro, R. What happens in a 5-year follow-up of benign thyroid nodules. J. Thyroid Res.,  2014, 2014, 1-4.
 [http://dx.doi.org/10.1155/2014/459791] [PMID: 25538855]

[6]
Papini, E.; Hegedüs, L. Minimally invasive ablative treatments for benign thyroid nodules: Current evidence and future directions. Thyroid,  2023, 33(8), 890-893.
 [http://dx.doi.org/10.1089/thy.2023.0263] [PMID: 37265153]

[7]
Mauri, G.; Gennaro, N.; Lee, M.K.; Baek, J.H. Laser and radiofrequency ablations for benign and malignant thyroid tumors. Int. J. Hyperthermia,  2019, 36(2), 13-20.
 [http://dx.doi.org/10.1080/02656736.2019.1622795] [PMID: 31537159]

[8]
Trimboli, P.; Castellana, M.; Piccardo, A.; Romanelli, F.; Grani, G.; Giovanella, L.; Durante, C. The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis. Rev. Endocr. Metab. Disord.,  2021, 22(2), 453-460.
 [http://dx.doi.org/10.1007/s11154-020-09592-3] [PMID: 32959174]

[9]
Cecoli, F.; Ceresola, E.M.; Altrinetti, V.; Cabria, M.; Cappagli, M.; Montepagani, A.; Cuttica, C.M.; Filippi, U.; Saverino, D.; Raffa, M.; Caputo, M.; Minuto, F.; Giusti, M.; Bagnasco, M. Therapeutic strategies and clinical outcome in papillary thyroid microcarcinoma: A multicenter observational study. Eur. Thyroid J.,  2016, 5(3), 180-186.
 [http://dx.doi.org/10.1159/000446746] [PMID: 27843808]

[10]
Mansouri, V.; Arjmand, B.; Rezaei Tavirani, M.; Razzaghi, M.; Rostami-Nejad, M.; Hamdieh, M. Evaluation of efficacy of low-level laser therapy. J. Lasers Med. Sci.,  2020, 11(4), 369-380.
 [http://dx.doi.org/10.34172/jlms.2020.60] [PMID: 33425286]

[11]
Papini, E.; Bizzarri, G.; Pacella, C.M. Percutaneous laser ablation of benign and malignant thyroid nodules. Curr. Opin. Endocrinol. Diabetes Obes.,  2008, 15(5), 434-439.
 [http://dx.doi.org/10.1097/MED.0b013e32830eb89a] [PMID: 18769216]

[12]
Mauri, G.; Cova, L.; Monaco, C.G.; Sconfienza, L.M.; Corbetta, S.; Benedini, S.; Ambrogi, F.; Milani, V.; Baroli, A.; Ierace, T.; Solbiati, L. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int. J. Hyperthermia,  2017, 33(3), 295-299.
 [http://dx.doi.org/10.1080/02656736.2016.1244707] [PMID: 27701923]

[13]
Ridouani, F.; Tuttle, R.M.; Ghosn, M.; Li, D.; Wong, R.J.; Fagin, J.A.; Monette, S.; Solomon, S.B.; Camacho, J.C. Ultrasound-guided percutaneous laser ablation of the thyroid gland in a swine model: Comparison of ablation parameters and ablation zone dimensions. Cardiovasc. Intervent. Radiol.,  2021, 44(11), 1798-1806.
 [http://dx.doi.org/10.1007/s00270-021-02915-0] [PMID: 34254175]

[14]
Gambelunghe, G.; Fede, R.; Bini, V.; Monacelli, M.; Avenia, N.; D’Ajello, M.; Colella, R.; Nasini, G.; De Feo, P. Ultrasound-guided interstitial laser ablation for thyroid nodules is effective only at high total amounts of energy: Results from a three-year pilot study. Surg. Innov.,  2013, 20(4), 345-350.
 [http://dx.doi.org/10.1177/1553350612459276] [PMID: 22991383]

[15]
Papini, E.; Monpeyssen, H.; Frasoldati, A.; Hegedüs, L. 2020 european thyroid association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules. Eur. Thyroid J.,  2020, 9(4), 172-185.
 [http://dx.doi.org/10.1159/000508484] [PMID: 32903999]

[16]
Pacella, C.M.; Bizzarri, G.; Guglielmi, R.; Anelli, V.; Bianchini, A.; Crescenzi, A.; Pacella, S.; Papini, E. Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology,  2000, 217(3), 673-677.
 [http://dx.doi.org/10.1148/radiology.217.3.r00dc09673] [PMID: 11110927]

[17]
Papini, E.; Guglielmi, R.; Bizzarri, G.; Pacella, C.M. Ultrasound-guided laser thermal ablation for treatment of benign thyroid nodules. Endocr. Pract.,  2004, 10(3), 276-283.
 [http://dx.doi.org/10.4158/EP.10.3.276] [PMID: 15310547]

[18]
Papini, E.; Guglielmi, R.; Bizzarri, G.; Graziano, F.; Bianchini, A.; Brufani, C.; Pacella, S.; Valle, D.; Pacella, C.M. Treatment of benign cold thyroid nodules: A randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid,  2007, 17(3), 229-235.
 [http://dx.doi.org/10.1089/thy.2006.0204] [PMID: 17381356]

[19]
Valcavi, R.; Riganti, F.; Bertani, A.; Formisano, D.; Pacella, C.M. Percutaneous laser ablation of cold benign thyroid nodules: A 3-year follow-up study in 122 patients. Thyroid,  2010, 20(11), 1253-1261.
 [http://dx.doi.org/10.1089/thy.2010.0189] [PMID: 20929405]

[20]
Papini, E.; Rago, T.; Gambelunghe, G.; Valcavi, R.; Bizzarri, G.; Vitti, P.; De Feo, P.; Riganti, F.; Misischi, I.; Di Stasio, E.; Pacella, C.M. Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J. Clin. Endocrinol. Metab.,  2014, 99(10), 3653-3659.
 [http://dx.doi.org/10.1210/jc.2014-1826] [PMID: 25050903]

[21]
Trimboli, P.; Castellana, M.; Sconfienza, L.M.; Virili, C.; Pescatori, L.C.; Cesareo, R.; Giorgino, F.; Negro, R.; Giovanella, L.; Mauri, G. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: A systematic review and meta-analysis. Endocrine,  2020, 67(1), 35-43.
 [http://dx.doi.org/10.1007/s12020-019-02019-3] [PMID: 31327158]

[22]
Bernardi, S.; Giudici, F.; Cesareo, R.; Antonelli, G.; Cavallaro, M.; Deandrea, M.; Giusti, M.; Mormile, A.; Negro, R.; Palermo, A.; Papini, E.; Pasqualini, V.; Raggiunti, B.; Rossi, D.; Sconfienza, L.M.; Solbiati, L.; Spiezia, S.; Tina, D.; Vera, L.; Stacul, F.; Mauri, G. Five-year results of radiofrequency and laser ablation of benign thyroid nodules: A multicenter study from the italian minimally invasive treatments of the thyroid group. Thyroid,  2020, 30(12), 1759-1770.
 [http://dx.doi.org/10.1089/thy.2020.0202] [PMID: 32578498]

[23]
Gambelunghe, G.; Stefanetti, E.; Avenia, N.; De Feo, P. Percutaneous ultrasound-guided laser ablation of benign thyroid nodules: Results of 10-year follow-up in 171 patients. J. Endocr. Soc.,  2021, 5(7), bvab081.
 [http://dx.doi.org/10.1210/jendso/bvab081] [PMID: 34159286]

[24]
Gambelunghe, G.; Ristagno, S.; Stefanetti, E.; Avenia, N.; De Feo, P. Ultrasound-guided laser ablation of very large benign thyroid nodules: 4-year, retrospective follow-up in 24 patients. Int. J. Hyperthermia,  2022, 39(1), 217-221.
 [http://dx.doi.org/10.1080/02656736.2022.2025923] [PMID: 35078372]

[25]
Pacella, C.M.; Mauri, G.; Achille, G.; Barbaro, D.; Bizzarri, G.; De Feo, P.; Di Stasio, E.; Esposito, R.; Gambelunghe, G.; Misischi, I.; Raggiunti, B.; Rago, T.; Patelli, G.L.; D’Este, S.; Vitti, P.; Papini, E. Outcomes and risk factors for complications of laser ablation for thyroid nodules: A multicenter study on 1531 patients. J. Clin. Endocrinol. Metab.,  2015, 100(10), 3903-3910.
 [http://dx.doi.org/10.1210/jc.2015-1964] [PMID: 26274342]

[26]
Mauri, G.; Pacella, C.M.; Papini, E.; Solbiati, L.; Goldberg, S.N.; Ahmed, M.; Sconfienza, L.M. Image-guided thyroid ablation: Proposal for standardization of terminology and reporting criteria. Thyroid,  2019, 29(5), 611-618.
 [http://dx.doi.org/10.1089/thy.2018.0604] [PMID: 30803397]

[27]
Negro, R.; Trimboli, P. Thermal ablation for benign, non-functioning thyroid nodules: A clinical review focused on outcomes, technical remarks, and comparisons with surgery. Electromagn. Biol. Med.,  2020, 39(4), 347-355.
 [http://dx.doi.org/10.1080/15368378.2020.1809448] [PMID: 32799679]

[28]
Negro, R.; Salem, T.M.; Greco, G. Laser ablation is more effective for spongiform than solid thyroid nodules. A 4-year retrospective follow-up study. Int. J. Hyperthermia,  2016, 32(7), 822-828.
 [http://dx.doi.org/10.1080/02656736.2016.1212279] [PMID: 27405595]

[29]
Papi, G.; Novizio, R.; Brunetti, M.; Mauri, G. Impact of the introduction of minimally invasive treatments of the thyroid (MITT) for benign thyroid nodules in an Italian hospital: A cost-minimization analysis. Endocrine,  2023, 82(1), 126-133.
 [http://dx.doi.org/10.1007/s12020-023-03403-w] [PMID: 37258994]

[30]
Negro, R.; Greco, G.; Deandrea, M.; Rucco, M.; Trimboli, P. Twelve-month volume reduction ratio predicts regrowth and time to regrowth in thyroid nodules submitted to laser ablation: A 5-year follow-up retrospective study. Korean J. Radiol.,  2020, 21(6), 764-772.
 [http://dx.doi.org/10.3348/kjr.2019.0798] [PMID: 32410415]

[31]
Papini, E.; Crescenzi, A.; D’Amore, A.; Deandrea, M.; De Benedictis, A.; Frasoldati, A.; Garberoglio, R.; Guglielmi, R.; Pio Lombardi, C.; Mauri, G.; Elisa Miceli, R.; Puglisi, S.; Rago, T.; Salvatore, D.; Triggiani, V.; Van Doorne, D.; Mitrova, Z.; Saulle, R.; Vecchi, S.; Basile, M.; Scoppola, A.; Paoletta, A.; Persichetti, A.; Samperi, I.; Cozzi, R.; Grimaldi, F.; Boniardi, M.; Camaioni, A.; Elisei, R.; Guastamacchia, E.; Nati, G.; Novo, T.; Salvatori, M.; Spiezia, S.; Vallone, G.; Zini, M.; Attanasio, R. Italian guidelines for the management of non-functioning benign and locally symptomatic thyroid nodules. Endocr. Metab. Immune Disord. Drug Targets,  2023, 23(6), 876-885.
 [http://dx.doi.org/10.2174/1871530323666230201104112] [PMID: 36722479]

[32]
Hamburger, J. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J. Clin. Endocrinol. Metab.,  1980, 50(6), 1089-1093.
 [http://dx.doi.org/10.1210/jcem-50-6-1089] [PMID: 7372787]

[33]
Døssing, H.; Bennedbæk, F.N.; Bonnema, S.J.; Grupe, P.; Hegedüs, L. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur. J. Endocrinol.,  2007, 157(1), 95-100.
 [http://dx.doi.org/10.1530/EJE-07-0094] [PMID: 17609407]

[34]
Gambelunghe, G.; Stefanetti, E.; Colella, R.; Monacelli, M.; Avenia, N.; De Feo, P. A single session of laser ablation for toxic thyroid nodules: three-year follow-up results. Int. J. Hyperthermia,  2018, 34(5), 631-635.
 [http://dx.doi.org/10.1080/02656736.2018.1437931] [PMID: 29409365]

[35]
Mauri, G.; Papini, E.; Bernardi, S.; Barbaro, D.; Cesareo, R.; De Feo, P.; Deandrea, M.; Fugazzola, L.; Gambelunghe, G.; Greco, G.; Messina, C.; Monti, S.; Mormile, A.; Negro, R.; Offi, C.; Palermo, A.; Persani, L.; Presciuttini, F.; Solbiati, L.A.; Spiezia, S.; Stacul, F.; Viganò, M.; Sconfienza, L.M. Image-guided thermal ablation in autonomously functioning thyroid nodules. A retrospective multicenter three-year follow-up study from the Italian Minimally Invasive Treatment of the Thyroid (MITT) Group. Eur. Radiol.,  2022, 32(3), 1738-1746.
 [http://dx.doi.org/10.1007/s00330-021-08289-8] [PMID: 34751793]

[36]
Chianelli, M.; Bizzarri, G.; Todino, V.; Misischi, I.; Bianchini, A.; Graziano, F.; Guglielmi, R.; Pacella, C.M.; Gharib, H.; Papini, E. Laser ablation and 131-iodine: A 24-month pilot study of combined treatment for large toxic nodular goiter. J. Clin. Endocrinol. Metab.,  2014, 99(7), E1283-E1286.
 [http://dx.doi.org/10.1210/jc.2013-2967] [PMID: 24684455]

[37]
Negro, R.; Greco, G. Quality of life and outcomes in patients with a large toxic adenoma undergoing laser ablation plus radioiodine vs lobectomy. Int. J. Hyperthermia,  2019, 36(1), 190-194.
 [http://dx.doi.org/10.1080/02656736.2018.1549335] [PMID: 30556434]

[38]
Jegerlehner, S.; Bulliard, J.L.; Aujesky, D.; Rodondi, N.; Germann, S.; Konzelmann, I.; Chiolero, A. Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study. PLoS One,  2017, 12(6), e0179387.
 [http://dx.doi.org/10.1371/journal.pone.0179387] [PMID: 28614405]

[39]
O’Grady, T.J.; Gates, M.A.; Boscoe, F.P. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011. Int. J. Cancer,  2015, 137(11), 2664-2673.
 [http://dx.doi.org/10.1002/ijc.29634] [PMID: 26069163]

[40]
Brito, JP.; Hay, ID.; Morris, JC. Low risk papillary thyroid cancer. BMJ,  2014, 16(348), g3045.
 [http://dx.doi.org/10.1136/bmj.g3045]

[41]
Koshkina, A.; Fazelzad, R.; Sugitani, I.; Miyauchi, A.; Thabane, L.; Goldstein, D.P.; Ghai, S.; Sawka, A.M. Association of patient age with progression of low-risk papillary thyroid carcinoma under active surveillance. JAMA Otolaryngol. Head Neck Surg.,  2020, 146(6), 552-560.
 [http://dx.doi.org/10.1001/jamaoto.2020.0368] [PMID: 32297926]

[42]
Papini, E.; Guglielmi, R.; Gharib, H.; Misischi, I.; Graziano, F.; Chianelli, M.; Crescenzi, A.; Bianchini, A.; Valle, D.; Bizzarri, G. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: A potential therapeutic approach in patients at surgical risk. Thyroid,  2011, 21(8), 917-920.
 [http://dx.doi.org/10.1089/thy.2010.0447] [PMID: 21595556]

[43]
Valcavi, R.; Piana, S.; Bortolan, G.S.; Lai, R.; Barbieri, V.; Negro, R. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: A feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid,  2013, 23(12), 1578-1582.
 [http://dx.doi.org/10.1089/thy.2013.0279] [PMID: 23978269]

[44]
Mauri, G.; Orsi, F.; Carriero, S.; Della Vigna, P.; De Fiori, E.; Monzani, D.; Pravettoni, G.; Grosso, E.; Manzoni, MF.; Ansarin, M.; Giugliano, G. Image-guided thermal ablation as an alternative to surgery for papillary thyroid microcarcinoma: Preliminary results of an italian experience. Front. Endocrinol.,  2021, 8(11), 575152.

[45]
Zhou, W.; Jiang, S.; Zhan, W.; Zhou, J.; Xu, S.; Zhang, L. Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: Preliminary results. Eur. Radiol.,  2017, 27(7), 2934-2940.
 [http://dx.doi.org/10.1007/s00330-016-4610-1] [PMID: 27853812]

[46]
Ji, L.; Wu, Q.; Gu, J.; Deng, X.; Zhou, W.; Fan, X.; Zhou, F. Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: A retrospective analysis of 37 patients. Cancer Imaging,  2019, 19(1), 16.
 [http://dx.doi.org/10.1186/s40644-019-0204-x] [PMID: 30894228]

[47]
Zhou, W.; Ni, X.; Xu, S.; Zhang, L.; Chen, Y.; Zhan, W. Ultrasound‐guided laser ablation versus microwave ablation for patients with unifocal papillary thyroid microcarcinoma: A retrospective study. Lasers Surg. Med.,  2020, 52(9), 855-862.
 [http://dx.doi.org/10.1002/lsm.23238] [PMID: 32216112]

[48]
Zhang, L.; Zhang, GP.; Zhan, WW.; Zhou, W. The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma. Front. Endocrinol.,  2022, 17(13), 921812.
 [http://dx.doi.org/10.3389/fendo.2022.921812]

[49]
Zhou, W.; Ni, X.; Xu, S.; Zhang, L.; Chen, Y.; Zhan, W. Ultrasound-guided laser ablation versus surgery for solitary papillary thyroid microcarcinoma: A retrospective study. Int. J. Hyperthermia,  2019, 36(1), 896-903.
 [http://dx.doi.org/10.1080/02656736.2019.1649475] [PMID: 31464140]

[50]
Peng, K.; Zhou, P.; Liu, W. Long-term efficacy of ultrasoundguided percutaneous laser ablation for low-risk papillary thyroid microcarcinoma: A 5-year follow-up study. Biomed. Res. Int.,  2021, 23(2021), 6616826.

[51]
Kim, H.J.; Chung, S.M.; Kim, H.; Jang, J.Y.; Yang, J.H.; Moon, J.S.; Son, G.; Oh, J.R.; Bae, J.Y.; Yoon, H. Long-term efficacy of ultrasound-guided laser ablation for papillary thyroid microcarcinoma: Results of a 10-year retrospective study. Thyroid,  2021, 31(11), 1723-1729.
 [http://dx.doi.org/10.1089/thy.2021.0151] [PMID: 34445885]

[52]
Mauri, G.; Hegedüs, L.; Bandula, S.; Cazzato, R.L.; Czarniecka, A.; Dudeck, O.; Fugazzola, L.; Netea-Maier, R.; Russ, G.; Wallin, G.; Papini, E. European thyroid association and cardiovascular and interventional radiological society of europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur. Thyroid J.,  2021, 10(3), 185-197.
 [http://dx.doi.org/10.1159/000516469] [PMID: 34178704]

[53]
Chen, S.; Mao, Y.; Chen, G. Economic effect between surgery and thermal ablation for patients with papillary thyroid microcarcinoma: A systemic review and meta-analysis. Endocrine,  2022, 76(1), 9-17.
 [http://dx.doi.org/10.1007/s12020-022-02991-3] [PMID: 35122627]

[54]
Rosario, P.; Mourão, G.; Calsolari, M. Role of adjuvant therapy with radioactive iodine in patients with elevated serum thyroglobulin after neck reoperation due to recurrent papillary thyroid cancer: A monoinstitutional comparative study. Endocrine,  2020, 68(1), 144-150.
 [http://dx.doi.org/10.1007/s12020-019-02165-8] [PMID: 31865556]

[55]
Choi, Y.; Jung, SL.; Bae, JS.; Lee, SH.; Jung, CK.; Jang, J.; Shin, NY.; Choi, HS.; Ahn, KJ.; Kim, BS. Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: A single-center propensity score matching study. Int. J. Hyperthermia,  2019, 36, 359-367.

[56]
Papini, E.; Bizzarri, G.; Bianchini, A.; Valle, D.; Misischi, I.; Guglielmi, R.; Salvatori, M.; Solbiati, L.; Crescenzi, A.; Pacella, C.M.; Gharib, H. Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J. Clin. Endocrinol. Metab.,  2013, 98(1), E92-E97.
 [http://dx.doi.org/10.1210/jc.2012-2991] [PMID: 23150695]

[57]
Mauri, G.; Cova, L.; Ierace, T.; Baroli, A.; Di Mauro, E.; Pacella, C.M.; Goldberg, S.N.; Solbiati, L. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc. Intervent. Radiol.,  2016, 39(7), 1023-1030.
 [http://dx.doi.org/10.1007/s00270-016-1313-6] [PMID: 26911732]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/0118715303275468231004105258	Print ISSN 1871-5303
Publisher Name Bentham Science Publisher	Online ISSN 2212-3873

Endocrine, Metabolic & Immune Disorders - Drug Targets

Laser Ablation for Benign and Malignant Thyroid Nodules – A Mini-Literature Review

Abstract Play Pause

Graphical Abstract

Related Journals

Related Books

Abstract